Insider Transactions in Q4 2025 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 29
2025
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Indirect |
77,840
-2.26%
|
$1,634,640
$21.35 P/Share
|
|
Oct 28
2025
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Indirect |
19,019
-1.6%
|
$380,380
$20.19 P/Share
|
|
Oct 28
2025
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.15%
|
$100,000
$20.0 P/Share
|
|
Oct 08
2025
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
37,792
-15.0%
|
$566,880
$15.05 P/Share
|
|
Oct 08
2025
|
Jennifer Jarrett Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,792
+13.04%
|
$37,792
$1.23 P/Share
|
|
Oct 06
2025
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,500
-5.51%
|
$175,000
$14.54 P/Share
|
|
Oct 06
2025
|
Jennifer Jarrett Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+5.23%
|
$12,500
$1.23 P/Share
|